All News ObsEva SA

Equities

OBSN

CH1260041939

End-of-day quote Swiss Exchange Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
0.0012 ^CHF	-76.92%		0.00%	-96.63%

Apr. 03	ObsEva to Delist from the SIX Swiss Exchange	MT
Mar. 20	ObsEva SA Announces to Wind-Down the Operations	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ObsEva to Delist from the SIX Swiss Exchange	Apr. 03	MT
ObsEva SA Announces to Wind-Down the Operations	Mar. 19	CI
ObsEva SA Announces Catarina Edfjäll to Step Down from the Board	Mar. 19	CI
ObsEva to Wind Down, Flags SIX Swiss Delisting	Feb. 28	MT
ObsEva Secures Temporary Moratorium Against Creditors	Jan. 31	MT
ObsEva to File for Moratorium in Geneva, Switzerland	Nov. 30	MT
ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals	Nov. 30	AQ
ObsEva to Return Global Rights on Ebopiprant to Xoma	23-10-30	MT
Organon Returns Ebopiprant to XOMA	23-10-27	AQ
ObsEva Net Loss Narrows in H1	23-09-27	MT
ObsEva SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-26	CI
ObsEva Terminates Licensing Deal with Yuyuan BioScience for Oral Oxytocin Receptor	23-07-13	MT
ObsEva Recovers Full Worldwide Rights on Nolasiban	23-07-13	AQ
ObsEva SA Announces Termination of Its Sub-Licensing Agreement with Yuyuan Bioscience	23-07-13	CI
SIX Group Makes Index Adjustments Following Review	23-07-11	MT
Switzerland's ObsEva Appoints Permanent CEO	23-05-02	MT
ObsEva SA announced that it expects to receive CHF 1.54 million in funding from ObsEva USA Inc.	22-12-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW